Amendment: SEC Form SCHEDULE 13D/A filed by Kewaunee Scientific Corporation
$KEQU
Medical Specialities
Industrials
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2)
|
KEWAUNEE SCIENTIFIC CORP /DE/ (Name of Issuer) |
Common Stock, $2.50 par value (Title of Class of Securities) |
492854104 (CUSIP Number) |
Anita G. Zucker c/o The InterTech Group, Inc., 4838 Jenkins Avenue North Charleston, SC, 29405 843-744-5174 Robert Johnston The InterTech Group, Inc., 4838 Jenkins Avenue North Charleston, SC, 29405 843-744-5174 Christopher J. Hubbert, Esq. Kohrman Jackson & Krantz LLP, 1375 E. Ninth Street, 29th Floor Cleveland, OH, 44114 216-696-8700 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
02/03/2025 (Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP No. | 492854104 |
| 1 |
Name of reporting person
Zucker Anita G | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
193,876.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
6.8 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| Item 1. | Security and Issuer | |
| (a) | Title of Class of Securities:
Common Stock, $2.50 par value | |
| (b) | Name of Issuer:
KEWAUNEE SCIENTIFIC CORP /DE/ | |
| (c) | Address of Issuer's Principal Executive Offices:
2700 W FRONT ST, STATESVILLE,
NORTH CAROLINA
, 28677. | |
Item 1 Comment:
This Amendment No. 2 to Schedule 13D relates to the common stock, $2.50 par value (the "Shares"), of Kewaunee Scientific Corporation ("Kewaunee") owned by Anita G. Zucker as the Trustee of The Article 6 Marital Trust under The First Amended and Restated Jerry Zucker Revocable Trust dated April 2, 2007 (the "Trust"). This amendment supplements Mrs. Zucker's initial Schedule 13D filed on October 30, 2019, as amended. | ||
| Item 5. | Interest in Securities of the Issuer | |
| (a) | The Trust owns 193,876 Shares, or 6.8% of Kewaunee's outstanding Shares based on 2,871,808 Shares outstanding as reported in Kewaunee's October 31, 2024 Quarterly Report on Form 10-Q. Mrs. Zucker, as trustee of the Trust, has sole voting, investment and dispositive power with respect to the Trust's Shares.
The Trust sold the 40,822 Shares listed in the table below in open market transactions through its broker. Neither Mrs. Zucker nor the Trust has effected any other transactions in the Shares of Kewaunee during the past sixty days. | |
| (b) | Date Shares Sold Price Per Share
12/13/24 5,000 $51.7595
12/13/24 5,000 $52.4937
12/18/24 2,781 $55.9447
12/26/24 2,219 $55.8748
12/26/24 5,000 $56.9177
12/26/24 2,000 $58.5642
1/7/25 9,000 $62.3544
1/22/25 2,660 $62.9172
1/23/25 2,958 $62.3052
1/24/25 1,182 $62.0511
1/30/24 600 $62.1466
2/3/25 215 $63.9600
2/3/25 100 $62.5600
2/3/25 181 $62.4900
2/3/25 250 $62.5200
2/3/25 100 $62.4550
2/3/25 300 $62.3200
2/3/25 100 $62.1250
2/3/25 100 $62.1300
2/3/25 200 $62.2800
2/3/25 100 $62.2400
2/3/25 7 $62.1700
2/3/25 31 $62.1500
2/3/25 300 $62.0400
2/3/25 438 $62.0200 | |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|